Catherine Allard

Dr. Catherine Allard

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ECEGG Consortium
EGG Consortium
NWNicole M. Warrington
Nicole M. Warrington
RBRobin N. Beaumont
Robin N. Beaumont
MHMomoko Horikoshi
Momoko Horikoshi
FDFelix R. Day
Felix R. Day
RFRachel M. Freathy
Rachel M. Freathy

16 May 2016 in Diabetes Care
Verified
Journal Article
Open access
PDF file
CPCamille E. Powe
Camille E. Powe
CACatherine Allard
Catherine Allard
MBMarie-Claude Battista
Marie-Claude Battista
MDMyriam Doyon
Myriam Doyon
LBLuigi Bouchard
Luigi Bouchard
MHMarie-France Hivert
Marie-France Hivert
OBJECTIVE: To characterize physiologic subtypes of gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS: Insulin sensitivity and secretion were estimated in 809 women at 24–30 weeks' gestation, using oral glucose tolerance test–based indices. In women with GDM (8.3%), defects in insulin sensitivity or secretion were defined below the 25th percentile in women with normal glucose tolerance (NGT). GDM subtypes were defined based on the defect(s) present. RESULTS: Relative to women with NGT, women with predominant insulin sensitivity defects (51% of GDM) had higher BMI and fasting glucose, larger infants (birth weight z score 0.57 [−0.01 to 1.37] vs. 0.03 [−0.53 to 0.52], P = 0.001), and greater risk of GDM-associated adverse outcomes (57.6 vs. 28.2%, P = 0.003); differences were independent of BMI. Women with predominant insulin secretion defects (30% of GDM) had BMI, fasting glucose, infant birth weights, and risk of adverse outcomes similar to those in women with NGT. CONCLUSIONS: Heterogeneity of physiologic processes underlying hyperglycemia exists among women with GDM. GDM with impaired insulin sensitivity confers a greater risk of adverse outcomes.

21 July 2017 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
GSGemma C Sharp
Gemma C Sharp
LSLucas A Salas
Lucas A Salas
CMClaire Monnereau
Claire Monnereau
CACatherine Allard
Catherine Allard
PYPaul Yousefi
Paul Yousefi
CRCaroline L Relton
Caroline L Relton
Pre-pregnancy maternal obesity is associated with adverse offspring outcomes at birth and later in life. Individual studies have shown that epigenetic modifications such as DNA methylation could contribute. Within the Pregnancy and Childhood Epigenetics (PACE) Consortium, we meta-analysed the association between pre-pregnancy maternal BMI and methylation at over 450,000 sites in newborn blood DNA, across 19 cohorts (9,340 mother-newborn pairs). We attempted to infer causality by comparing the effects of maternal versus paternal BMI and incorporating genetic variation. In four additional cohorts (1,817 mother-child pairs), we meta-analysed the association between maternal BMI at the start of pregnancy and blood methylation in adolescents. In newborns, maternal BMI was associated with small (<0.2% per BMI unit (1 kg/m2), P < 1.06 × 10−7) methylation variation at 9,044 sites throughout the genome. Adjustment for estimated cell proportions greatly attenuated the number of significant CpGs to 104, including 86 sites common to the unadjusted model. At 72/86 sites, the direction of the association was the same in newborns and adolescents, suggesting persistence of signals. However, we found evidence for acausal intrauterine effect of maternal BMI on newborn methylation at just 8/86 sites. In conclusion, this well-powered analysis identified robust associations between maternal adiposity and variations in newborn blood DNA methylation, but these small effects may be better explained by genetic or lifestyle factors than a causal intrauterine mechanism. This highlights the need for large-scale collaborative approaches and the application of causal inference techniques in epigenetic epidemiology.

23 May 2018 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
NTN Tabatabaei
N Tabatabaei
AEAm Eren
Am Eren
LBLb Barreiro
Lb Barreiro
VYV Yotova
V Yotova
ADA Dumaine
A Dumaine
WFWd Fraser
Wd Fraser
Objectives: To explore differences in the vaginal microbiome between preterm and term deliveries.Design: Nested case–control study in 3D cohort (design, develop, discover).Setting: Quebec, Canada.Sample: Ninety‐four women with spontaneous preterm birth as cases [17 early (<34 weeks) and 77 late (34–36 weeks) preterm birth] and 356 women as controls with term delivery (≥37 weeks).Methods: To assess the vaginal microbiome by sequencing the V4 region of the 16S ribosomal RNA (rRNA) gene in swabs self‐collected during early pregnancy.Main outcome measures: Comparison of relative abundance of bacterial operational taxonomic units and oligotypes and identifying vaginal community state types (CSTs) in early or late spontaneous preterm and term deliveries.Results: Lactobacillus gasseri/ Lactobacillus johnsonii (coefficient −5.36, 95% CI −8.07 to −2.65), Lactobacillus crispatus (99%)/ Lactobacillus acidophilus (99%) (−4.58, 95% CI −6.20 to −2.96), Lactobacillus iners (99%)/ Ralstonia solanacearum (99%) (−3.98, 95% CI −6.48 to −1.47) and Bifidobacterium longum/ Bifidobacterium breve (−8.84, 95% CI −12.96 to −4.73) were associated with decreased risk of early but not late preterm birth. Six vaginal CSTs were identified: four dominated by Lactobacillus; one with presence of bacterial vaginosis‐associated bacteria (Gardnerella vaginalis, Atopobium vaginae and Veillonellaceae bacterium) (CST IV); and one with nondominance of Lactobacillus (CST VI). CST IV was associated with increased risk of early (4.22, 95% CI 1.24–24.85) but not late (1.63, 95% CI 0.68–5.04) preterm birth, compared with CST VI.Conclusions: Lactobacillus gasseri/L. johnsonii, L. crispatus/L. acidophilus, L. iners/R. solanacearum and B. longum/B. breve may be associated with decreased risk of early preterm birth. A bacterial vaginosis‐related vaginal CST versus a CST nondominated by Lactobacillus may be associated with increased risk of early preterm birth.Tweetable Largest study of its kind finds certain species of vaginal Lactobacillus + Bifidobacterium may relate to lower risk of preterm birth.

23 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
LKLeanne K. Küpers
Leanne K. Küpers
CMClaire Monnereau
Claire Monnereau
GSGemma C Sharp
Gemma C Sharp
PYPaul Yousefi
Paul Yousefi
LSLucas A Salas
Lucas A Salas
JFJanine F. Felix
Janine F. Felix
Birthweight is associated with health outcomes across the life course, DNA methylation may be an underlying mechanism. In this meta-analysis of epigenome-wide association studies of 8,825 neonates from 24 birth cohorts in the Pregnancy And Childhood Epigenetics Consortium, we find that DNA methylation in neonatal blood is associated with birthweight at 914 sites, with a difference in birthweight ranging from −183 to 178 grams per 10% increase in methylation (PBonferroni < 1.06 x 10−7). In additional analyses in 7,278 participants, <1.3% of birthweight-associated differential methylation is also observed in childhood and adolescence, but not adulthood. Birthweight-related CpGs overlap with some Bonferroni-significant CpGs that were previously reported to be related to maternal smoking (55/914,p = 6.12 x 10−74) and BMI in pregnancy (3/914,p= 1.13x10−3), but not with those related to folate levels in pregnancy. Whether the associations that we observe are causal or explained by confounding or fetal growth influencing DNA methylation (i.e. reverse causality) requires further research.

3 January 2018 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
RBRobin N Beaumont
Robin N Beaumont
NWNicole M Warrington
Nicole M Warrington
ACAlana Cavadino
Alana Cavadino
JTJessica Tyrrell
Jessica Tyrrell
MNMichael Nodzenski
Michael Nodzenski
RFRachel M. Freathy
Rachel M. Freathy
Genome-wide association studies of birth weight have focused on fetal genetics, whereas relatively little is known about the role of maternal genetic variation. We aimed to identify maternal genetic variants associated with birth weight that could highlight potentially relevant maternal determinants of fetal growth. We meta-analysed data on up to 8.7 million SNPs in up to 86 577 women of European descent from the Early Growth Genetics (EGG) Consortium and the UK Biobank. We used structural equation modelling (SEM) and analyses of mother–child pairs to quantify the separate maternal and fetal genetic effects. Maternal SNPs at 10 loci (MTNR1B, HMGA2, SH2B3, KCNAB1, L3MBTL3, GCK, EBF1, TCF7L2, ACTL9, CYP3A7) were associated with offspring birth weight at P < 5 × 10−8. In SEM analyses, at least 7 of the 10 associations were consistent with effects of the maternal genotype acting via the intrauterine environment, rather than via effects of shared alleles with the fetus. Variants, or correlated proxies, at many of the loci had been previously associated with adult traits, including fasting glucose (MTNR1B, GCK and TCF7L2) and sex hormone levels (CYP3A7), and one (EBF1) with gestational duration. The identified associations indicate that genetic effects on maternal glucose, cytochrome P450 activity and gestational duration, and potentially on maternal blood pressure and immune function, are relevant for fetal growth. Further characterization of these associations in mechanistic and causal analyses will enhance understanding of the potentially modifiable maternal determinants of fetal growth, with the goal of reducing the morbidity and mortality associated with low and high birth weights.